← Latest news 
Granules to tighten oversight after US FDA warning as it digitizes records and boosts compliance controls
Business
Published on 24 April 2026
US scrutiny pushed Granules to automate records
Granules India says it will strengthen its manufacturing oversight after a US FDA warning related to documentation practices and contamination concerns. The company plans to digitize workflows and automate record management to improve data accuracy and compliance. Granules is positioning the reforms as proactive steps to address regulatory pressure while maintaining product quality across its facilities.
- Granules India faces heightened US FDA scrutiny over documentation
- Contamination concerns are part of the regulatory focus
- The firm will digitize processes and automate record management
- Goal is stronger compliance and consistent product quality
Read the full story at The Economic Times
This summarization was done by Beige for a story published on 
The Economic Times